Journal article
Low-molecular-weight heparin in the treatment of pulmonary embolism.
Abstract
Unfractionated heparin is the traditional treatment of choice for patients presenting with submassive pulmonary embolism. However, newer low-molecular-weight heparins have been developed and tested in several clinical trials in the last 2 decades because of the many limitations of unfractionated heparin. The pharmacologic properties of the low-molecular-weight heparins allow them to be administered subcutaneously in fixed, weight-adjusted doses …
Authors
Ageno W; Turpie AG
Journal
Seminars in Vascular Surgery, Vol. 13, No. 3, pp. 189–193
Publication Date
9 2000
ISSN
0895-7967